Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Sales: 2024-2025

Historic Return on Sales for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to 17.40%.

  • Inhibrx Biosciences' Return on Sales was N/A to 17.40% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.40%, marking a year-over-year change of. This contributed to the annual value of -133.18% for FY2023, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Inhibrx Biosciences' Return on Sales is 17.40%, which was up 17.92% from 14.76% recorded in Q2 2025.
  • In the past 5 years, Inhibrx Biosciences' Return on Sales ranged from a high of 42.67% in Q1 2024 and a low of -143.54% during Q4 2024.
  • For the 2-year period, Inhibrx Biosciences' Return on Sales averaged around -52.53%, with its median value being -46.20% (2025).
  • Within the past 5 years, the most significant YoY rise in Inhibrx Biosciences' Return on Sales was 15,410bps (2025), while the steepest drop was 14,982bps (2025).
  • Inhibrx Biosciences' Return on Sales (Quarterly) stood at -143.54% in 2024, then soared by 15,410bps to 17.40% in 2025.
  • Its Return on Sales stands at 17.40% for Q3 2025, versus 14.76% for Q2 2025 and -107.15% for Q1 2025.